Aklog Lishan - 02 Apr 2026 Form 4 Insider Report for PAVmed Inc. (PAVM)

Reporting relationship: Chairman and CEO, Director
Issuer ticker: PAVM
Reported as of: 02 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Apr 2026, 18:53:45 UTC
Prior SEC filing: 24 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Michael A. Gordon, by power of attorney

Key filing fact

Aklog Lishan filed Form 4 for PAVmed Inc. (PAVM) on 03 Apr 2026.

Key facts

This page summarizes Aklog Lishan's Form 4 filing for PAVmed Inc. (PAVM).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 Apr 2026, 18:53.

Change

Previous filing in this sequence was filed on 24 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001665074 Primary reporting owner

Aklog Lishan

Relationship: Chairman and CEO, Director
Address: 360 MADISON AVENUE, 25TH FLOOR, NEW YORK
Signature: /s/ Michael A. Gordon, by power of attorney
Signature date: 02 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PAVM transaction

Common Stock

Award

Transaction value
Shares: +350,000
Change %: +4597%
Price: $0.000000^*
Shares after: 357,614
Date: 02 Apr 2026
Ownership: Direct
Footnotes: F1

PAVM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 5
Date: 02 Apr 2026
Ownership: By daughter

PAVM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 5
Date: 02 Apr 2026
Ownership: By son

PAVM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 9,904
Date: 02 Apr 2026
Ownership: By Pavilion Venture Partners LLC
Footnotes: F2

PAVM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 45
Date: 02 Apr 2026
Ownership: By HCFP/AG LLC
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents restricted stock granted to the reporting person under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed.

Footnote F2

Dr. Aklog is a member and sole manager of Pavilion Venture Partners LLC, and therefore has sole voting and dispositive power over the securities held by this entity. Dr. Aklog disclaims beneficial ownership of securities held by this entity, except to the extent of his proportionate pecuniary interest therein.

Footnote F3

Dr. Aklog is a co-manager of HCFP/AG LLC, and therefore has joint voting and dispositive power over the securities held by this entity. Dr. Aklog disclaims beneficial ownership of securities held by this entity, except to the extent of his proportionate pecuniary interest therein.